BioHealth Upgrades & Downgrades on Wall Street (GHDX, GENZ, GSK, ISPH, LXRX, MEDX, MRK, QLTI, SHPGY)
September 8, 2008 · Filed Under daily · Comments Off
There have been other calls in drug, biotech, and healthcare stocks today but these are the key standouts that have been seen making an impact on stocks after the open of trading:
- Genomic Health (GHDX) Cut To Hold at Canaccord.
- Genzyme (GENZ) Started as Overweight at Morgan Stanley.
- GlaxoSmithKline (GSK) Cut to Sell at Goldman Sachs.
- Inspire Pharma (ISPH) Cut To Underweight at Morgan Stanley.
- Lexicon Pharma (LXRX) Cut to Underweight at Morgan Stanley.
- Medarex (MEDX) Cut to Equalweight at Morgan Stanley.
- Merck (MRK) Raised to Buy at Goldman Sachs.
- QLT (QLTI) Cut to Underweight at Morgan Stanley.
- Shire (SHPGY) Cut to Neutral from Buy at Goldman Sachs.
Jon C. Ogg
September 8, 2008
Analysts Weighing In On BioHealth Stocks (AUXL, AVRX, CPHD, MEND, AMED)
August 14, 2008 · Filed Under General · Comments Off
These are some of the analyst calls impacting biotech, medical, and healthcare stocks right at the open this Thursday morning:
- Auxilium Pharmaceuticals (AUXL) Cut to Neutral from BUY at B of A.
- Avalon Pharma (AVRX) Cut to Hold from Buy at Cantor Fitzgerald.
- Cepheid (CPHD) Cut to Neutral from Buy at UBS.
- Micrus Endovascular (MEND) Started as Hold at Needham & Co.
Amedisys (AMED) Raised to Outperform from Mkt Perform By Wachovia… more into home based healthcare and hospice, but involves caring for the aged and ill.
Jon C. Ogg
August 14, 2008
BioHealth Pre-Market Analyst Calls
August 6, 2008 · Filed Under General · Comments Off
Today we are seeing pretty thin coverage from analysts regarding biotech, drug, and healthcare stocks. These are the few we are seeing with over 90 minutes to to go before the market opens:
- Elan (ELN) Raised to Equal-weight at Lehman.
- Health Net (HNT) Cut to Hold at Citigroup.
- Novartis (NVS) Cut to Neutral at JPMorgan.
Jon C. Ogg
August 6, 2008